Evolution of Resistance Against CRISPR/Cas9 Gene Drive

被引:184
作者
Unckless, Robert L. [1 ]
Clark, Andrew G. [2 ,3 ]
Messer, Philipp W. [3 ]
机构
[1] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA
[2] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA
[3] Cornell Univ, Dept Biol Stat & Computat Biol, 102J Weill Hall, Ithaca, NY 14853 USA
基金
美国国家卫生研究院;
关键词
CRISPR/Cas9; gene drive; homing drive; mutagenic chain reaction; whole population replacement; MUTAGENIC CHAIN-REACTION; SOFT SELECTIVE SWEEPS; DROSOPHILA-MELANOGASTER; NATURAL-POPULATIONS; PEST-MANAGEMENT; ADAPTATION; FIXATION; MUTATION; VECTOR; SYSTEM;
D O I
10.1534/genetics.116.197285
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
CRISPR/Cas9 gene drive (CGD) promises to be a highly adaptable approach for spreading genetically engineered alleles throughout a species, even if those alleles impair reproductive success. CGD has been shown to be effective in laboratory crosses of insects, yet it remains unclear to what extent potential resistance mechanisms will affect the dynamics of this process in large natural populations. Here we develop a comprehensive population genetic framework for modeling CGD dynamics, which incorporates potential resistance mechanisms as well as random genetic drift. Using this framework, we calculate the probability that resistance against CGD evolves from standing genetic variation, de novo mutation of wild-type alleles, or cleavage repair by nonhomologous end joining (NHEJ)-a likely by-product of CGD itself. We show that resistance to standard CGD approaches should evolve almost inevitably in most natural populations, unless repair of CGD-induced cleavage via NHEJ can be effectively suppressed, or resistance costs are on par with those of the driver. The key factor determining the probability that resistance evolves is the overall rate at which resistance alleles arise at the population level by mutation or NHEJ. By contrast, the conversion efficiency of the driver, its fitness cost, and its introduction frequency have only minor impact. Our results shed light on strategies that could facilitate the engineering of drivers with lower resistance potential, and motivate the possibility to embrace resistance as a possible mechanism for controlling a CGD approach. This study highlights the need for careful modeling of the population dynamics of CGD prior to the actual release of a driver construct into the wild.
引用
收藏
页码:827 / 841
页数:15
相关论文
共 50 条
[41]   Engineering resistance against Tomato yellow leaf curl virus via the CRISPR/Cas9 system in tomato [J].
Tashkandi, Manal ;
Ali, Zahir ;
Aljedaani, Fatimah ;
Shami, Ashwag ;
Mahfouz, Magdy M. .
PLANT SIGNALING & BEHAVIOR, 2018, 13 (10)
[42]   Modeling Disease In Vivo With CRISPR/Cas9 [J].
Dow, Lukas E. .
TRENDS IN MOLECULAR MEDICINE, 2015, 21 (10) :609-621
[43]   CRISPR/Cas9 genome editing in wheat [J].
Kim, Dongjin ;
Alptekin, Burcu ;
Budak, Hikmet .
FUNCTIONAL & INTEGRATIVE GENOMICS, 2018, 18 (01) :31-41
[44]   Recent Progress in CRISPR/Cas9 Technology [J].
Mei, Yue ;
Wang, Yan ;
Chen, Huiqian ;
Sun, Zhong Sheng ;
Ju, Xing-Da .
JOURNAL OF GENETICS AND GENOMICS, 2016, 43 (02) :63-75
[45]   Engineering Plant Immunity: Using CRISPR/Cas9 to Generate Virus Resistance [J].
Zaidi, Syed Shan-e-Ali ;
Tashkandi, Menai ;
Mansoor, Shahid ;
Mahfouz, Magdy M. .
FRONTIERS IN PLANT SCIENCE, 2016, 7
[46]   What rheumatologists need to know about CRISPR/Cas9 [J].
Gibson, Gary J. ;
Yang, Maozhou .
NATURE REVIEWS RHEUMATOLOGY, 2017, 13 (04) :205-216
[47]   Microinjection of CRISPR/Cas9 Protein into Channel Catfish, Ictalurus punctatus, Embryos for Gene Editing [J].
Elaswad, Ahmed ;
Khalil, Karim ;
Cline, David ;
Page-McCaw, Patrick ;
Chen, Wenbiao ;
Michel, Maximilian ;
Cone, Roger ;
Dunham, Rex .
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2018, (131)
[48]   Modulating CRISPR gene drive activity through nucleocytoplasmic localization of Cas9 in S. cerevisiae [J].
Goeckel M.E. ;
Basgall E.M. ;
Lewis I.C. ;
Goetting S.C. ;
Yan Y. ;
Halloran M. ;
Finnigan G.C. .
Fungal Biology and Biotechnology, 6 (1)
[49]   CRISPR/Cas9 gene editing therapies for cystic fibrosis [J].
Graham, Carina ;
Hart, Stephen .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (06) :767-780
[50]   CRISPR/Cas9 gene editing for genodermatoses: progress and perspectives [J].
Naso, Gaetano ;
Petrova, Anastasia .
EMERGING TOPICS IN LIFE SCIENCES, 2019, 3 (03) :313-326